Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Esophageal Neoplasms × pertuzumab × Clear all

Sponsor

Conditions

Breast Neoplasms 41 Ovarian Neoplasms 4 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Solid Tumor 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Inflammatory Breast Neoplasms 2 HER2-positive Breast Cancer 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Patient Preference 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Multiple Endocrine Neoplasia 1 Malignant Solid Neoplasm 1 Lung Neoplasms 1 Locally Advanced Breast Cancer 1 Her2-Positive Breast Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-positive Early Breast Cancer 1 Fallopian Tube Neoplasms 1 Carcinoma, Neuroendocrine 1 Carcinoid Tumor 1 Breast Neoplasms, Male 1 Biliary Tract Neoplasms 1

Interventions

Fluorouracil 32 Cisplatin 32 Radiotherapy 29 Oxaliplatin 28 Paclitaxel 20 Irinotecan 20 Docetaxel 20 pembrolizumab 19 Leucovorin 18 Capecitabine 16 Cetuximab 11 Bevacizumab 11 Carboplatin 10 Radiation 9 Trastuzumab 8 Surgical Procedures, Operative 8 Panitumumab 6 Epirubicin 5 Neoadjuvant Therapy 4 Esophagectomy 4 Erlotinib Hydrochloride 4 tisotumab vedotin 3 durvalumab 3 Sunitinib 3 Gemcitabine 3 Chemotherapy, Adjuvant 3 Albumin-Bound Paclitaxel 3 pegfilgrastim 2 niraparib 2 epacadostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡